Ketek review scheduled
Executive Summary
FDA's Anti-Infective Drugs Advisory Committee will meet at the Marriott Washingtonian Center in Gaithersburg, Md., Jan. 8 at 8 a.m. to review Aventis' Ketek for three anti-infective indications. Aventis previously announced the meeting (1"The Pink Sheet" Nov. 4, p. 16). On Jan. 9, the committee will review the Center for Veterinary Medicine's proposed approach to ranking antimicrobial drugs relative to their importance in human medicine as a basis for risk assessments in development of new animal drugs...